NV
Neeraj Vishwakarma
About Neeraj Vishwakarma
Data last updated:
Neeraj Vishwakarma is a Director at Criti - On Remedies Private Limited (since 2025) and Director at Anay Pharmaceutical Private Limited (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Criti - On Remedies Private Limited U46497UP2025PTC228678 | Director | 25 Jul 2025 | 2025 | Active | |
| Anay Pharmaceutical Private Limited U46497MP2023PTC067599 | Director | 04 Dec 2024 | 2023 | Active |
Board colleagues of Neeraj Vishwakarma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Diwakar Gore | 10860692 | Criti - On Remedies Private Limited , Anay Pharmaceutical Private Limited | Director |
| Milan Kumar Soni | 11213503 | Criti - On Remedies Private Limited | Director |
| Shishir Dixit | 11213504 | Criti - On Remedies Private Limited | Director |
| Vidyut Vinayak | 11213502 | Criti - On Remedies Private Limited | Director |
| Kuldeep Singh | 09094211 | Anay Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neeraj Vishwakarma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neeraj Vishwakarma
Neeraj Vishwakarma currently holds 2 directorships: Criti - On Remedies Private Limited (Director, since 25 Jul 2025); Anay Pharmaceutical Private Limited (Director, since 04 Dec 2024).
Neeraj Vishwakarma was first appointed on 04 Dec 2024 as Director at Anay Pharmaceutical Private Limited. The most recent appointment on record is 25 Jul 2025 at Criti - On Remedies Private Limited.
The current boards of Neeraj Vishwakarma's companies include Diwakar Gore (Criti - On Remedies Private Limited), Milan Kumar Soni (Criti - On Remedies Private Limited), Shishir Dixit (Criti - On Remedies Private Limited), Vidyut Vinayak (Criti - On Remedies Private Limited), Kuldeep Singh (Anay Pharmaceutical Private Limited).